We are live on ! Find out more
IA

IFP Advisors Portfolio holdings

AUM $5.54B
1-Year Est. Return 27.43%
This Fund
S&P 500
This Quarter Est. Return
-11.76%
1 Year Est. Return
+27.43%
3 Year Est. Return
+73.16%
5 Year Est. Return
+63.71%
10 Year Est. Return
AUM
$1.64B
AUM Growth
-$813M
Cap. Flow
-$519M
Cap. Flow %
-31.62%
Top 10 Hldgs %
13.92%
Holding
4,153
New
193
Increased
822
Reduced
1,987
Closed
433

Sector Composition

Rank Sector Weight
1 Technology 6.31%
2 Financials 6.17%
3 Healthcare 5.53%
4 Consumer Discretionary 4.65%
5 Communication Services 3.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KNOW
2151
DELISTED
Direxion All Cap Insider Sentiment Shares
KNOW
$20K ﹤0.01%
600
-300
-33% -$11.3K
BGG
2152
DELISTED
Briggs & Stratton Corp.
BGG
$20K ﹤0.01%
1,536
+968
+170% +$14.9K
VSTO
2153
DELISTED
Vista Outdoor Inc.
VSTO
$20K ﹤0.01%
1,807
+81
+5% +$1.06K
JHMF
2154
DELISTED
John Hancock Multifactor Financials ETF
JHMF
$20K ﹤0.01%
642
ACAD icon
2155
Acadia Pharmaceuticals
ACAD
$4.51B
$19K ﹤0.01%
1,186
+750
+172% +$14.6K
ACGL icon
2156
Arch Capital
ACGL
$35.7B
$19K ﹤0.01%
723
+132
+22% +$3.65K
ADVM
2157
DELISTED
Adverum Biotechnologies
ADVM
$19K ﹤0.01%
600
AER icon
2158
AerCap
AER
$23.4B
$19K ﹤0.01%
480
-601
-56% -$30.1K
ATMP icon
2159
iPath Select MLP ETN
ATMP
$635M
$19K ﹤0.01%
1,069
BMRN icon
2160
BioMarin Pharmaceuticals
BMRN
$11.9B
$19K ﹤0.01%
222
+71
+47% +$6.75K
CRESY
2161
Cresud
CRESY
$806M
$19K ﹤0.01%
1,702
-1
-0.1% -$11
CRSP icon
2162
CRISPR Therapeutics
CRSP
$4.69B
$19K ﹤0.01%
720
+15
+2% +$521
EPHE icon
2163
iShares MSCI Philippines ETF
EPHE
$132M
$19K ﹤0.01%
594
-1,553
-72% -$47.3K
FMN
2164
Federated Hermes Premier Municipal Income Fund
FMN
$87.2M
$19K ﹤0.01%
1,582
FTI icon
2165
TechnipFMC
FTI
$28.6B
$19K ﹤0.01%
1,328
-570
-30% -$10.6K
HEZU icon
2166
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$560M
$19K ﹤0.01%
715
-2,970
-81% -$82.1K
HUBS icon
2167
HubSpot
HUBS
$12.9B
$19K ﹤0.01%
150
HY icon
2168
Hyster-Yale Materials Handling
HY
$576M
$19K ﹤0.01%
308
+208
+208% +$13K
IPKW icon
2169
Invesco International BuyBack Achievers ETF
IPKW
$543M
$19K ﹤0.01%
647
+353
+120% +$11K
IVOG icon
2170
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.6B
$19K ﹤0.01%
326
+38
+13% +$2.47K
JPC icon
2171
Nuveen Preferred & Income Opportunities Fund
JPC
$2.88B
$19K ﹤0.01%
2,275
-966
-30% -$8.54K
KRO icon
2172
KRONOS Worldwide
KRO
$712M
$19K ﹤0.01%
1,624
MTH icon
2173
Meritage Homes
MTH
$4.78B
$19K ﹤0.01%
1,030
MVV icon
2174
ProShares Ultra MidCap400
MVV
$150M
$19K ﹤0.01%
651
-1,417
-69% -$52.6K
PBR icon
2175
Petrobras
PBR
$120B
$19K ﹤0.01%
1,422
-963
-40% -$13.9K

Similar funds

IFP Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, IFP Advisors held 4,153 positions worth $1.64B, down 33% from $2.45B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

IFP Advisors withdrew a net $519M in Q4 2018, closing 433 positions and reducing 1,987 holdings. Its most notable exit was Corporate Capital Trust, Inc., an estimated $3.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 6.6% a quarter earlier, followed by Financials and Healthcare.

Against the trend, IFP Advisors opened a new position in iShares Core MSCI International Developed Markets ETF worth $358K.

  • IFP Advisors's largest Q4 2018 buy was iShares Core MSCI International Developed Markets ETF: 7,350 shares worth $358K.
  • IFP Advisors added most to First Trust Enhanced Short Maturity ETF in Q4 2018, an estimated $4.69M increase.
  • IFP Advisors's biggest Q4 2018 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $36.8M.
  • IFP Advisors fully exited Corporate Capital Trust, Inc. in Q4 2018, selling an estimated $3.46M.
  • IFP Advisors's ten largest holdings make up 14% of its $1.64B portfolio in Q4 2018.
  • IFP Advisors opened 193 new positions and closed 433 in Q4 2018.
  • IFP Advisors's portfolio value fell 33% quarter-over-quarter to $1.64B.

Based on IFP Advisors's 13F filing for Q4 2018, filed 23 Jan 2019.